|
|
Volumn 17, Issue 9, 2000, Pages 489-495
|
|
Generic human menopausal gonadotropin (hMG) in place of more costly follicle-stimulating hormone (FSH) for routine ovulation induction
|
|
Author keywords
Follicle stimulating hormone (FSH); Human menopausal gonadotropin; Ovulation induction
|
|
Indexed keywords
FOLLITROPIN;
HUMAN MENOPAUSAL GONADOTROPIN;
RECOMBINANT FOLLITROPIN;
UROFOLLITROPIN;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG EFFICACY;
FEMALE;
FEMALE INFERTILITY;
HUMAN;
MAJOR CLINICAL STUDY;
OVULATION INDUCTION;
PREGNANCY RATE;
PRIORITY JOURNAL;
REVIEW;
FEMALE;
FOLLICLE STIMULATING HORMONE;
FOLLOW-UP STUDIES;
HUMANS;
MENOTROPINS;
OVULATION INDUCTION;
PREGNANCY;
PREGNANCY RATE;
PROSPECTIVE STUDIES;
TREATMENT OUTCOME;
|
|
EID: 0033636341
PISSN: 10580468
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1009477523136 Document Type: Review |
|
Times cited : (8)
|
|
References (10)
|
